As reported on BioPharmaDive, Aardvark Therapeutics has halted dosing and enrollment in its late‑stage HERO trial for ARD‑101, a first‑in‑class treatment candidate for Prader–Willi syndrome
Editor’s Note: Patient Worthy is pleased to bring you this article, originally shared with us by our friend Julie Lanford, The Cancer Dietitian. To see
The landscape of advanced breast cancer treatment is shifting. Genentech’s filing acceptance of giredestrant, an experimental oral medication, represents a pivotal moment for thousands of
As reported in Business Wire, Vico Therapeutics has initiated patient dosing in an expanded cohort of its Phase 1/2a clinical study evaluating VO659, an antisense
Editor’s Note: This article was shared with us by our friends at Heal Canada. To see the article in its original format, please click here.
AbbVie has announced a landmark regulatory milestone with the US FDA’s approval of a supplemental new drug application (sNDA) for the combination of Venclexta (venetoclax)
As published in Sleep Review Magazine, Axsome Therapeutics has officially begun dosing patients in its Phase 3 CLARITY trial, a study designed to evaluate solriamfetol
Fibrosis, the accumulation of scar tissue in organs, disrupts normal organ function and leads to progressive impairment. Currently, there is no cure, and existing treatments
The relationship between people with type 1 diabetes and their medication has always been complicated. For decades, managing the condition has required constant vigilance including
As reported on PharmaBiz, Harness Therapeutics has selected HRN001 as its lead therapeutic candidate for Huntington’s disease (HD), marking a major milestone for the company
Click here to see Part 1 of of this 3 part pain series. If you suffer with chronic pain, you not only live with the unrelenting
Patients using Zepbound for weight management now have a simpler option for administering their medication. As reported by PharmaLive.com, Eli Lilly received FDA clearance for
On this episode of Wait, How Do You Spell That?, host Bree Clare sits down with Dr. Charles Link, a pioneering oncologist whose career has
At 44 years old, I was ready to hit the reset button. In March of 2025, my partner and I stepped away from our careers.
Ovarian cancer is a serious gynecological cancer with no reliable screening test, resulting in limited treatment options and a low number of survivors. Each year
Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for Priority Review the Biologics License Application (BLA) for garetosmab, marking a significant
AstraZeneca and Daiichi Sankyo’s antibody‑drug conjugate Datroway (datopotamab deruxtecan) has been granted Priority Review by the U.S. Food and Drug Administration (FDA) for use as
As a little girl, I believed miracles only existed in movies. They felt distant, beautiful stories meant for someone else. I never imagined that my
Telix Pharmaceuticals Advances Brain Cancer Imaging with European Regulatory Submission bit.ly/4lGIZJx Read now at PatientWorthy.com
#PatientWorthy #BrainCancer #TelixPharmaceuticals
This week at Patient Worthy, we’re dedicating our focus to individuals and families affected by Non‑Small Cell Lung Cancer. All week long, we’ll be amplifying patient voices, sharing informative resources, and building a space rooted in understanding, compassion, and connection.
Whether you’re navigating a diagnosis, supporting a loved one, or looking to learn more, patientworthy.com offers stories, updates, and guidance created with the community in mind. You’re not alone! Your experiences and perspectives truly matter.
Interested in sharing your journey? Click the link below to tell your story.
bit.ly/4dV7gru
#PatientWorthy #NSCLC #NonSmallCellLungCancer #LungCancerAwareness #ShareYourStory
Stories can be a powerful way to help children understand things that feel complicated. This one brings PKU into a space kids can connect with, reminding them that challenges don’t take away from who they are or what makes them special.
Thank you to Caitlin for writing this story and sharing Daniel’s PKU journey. By putting your experience into words, you're helping other children and families feel seen and truly making a difference in the lives of those navigating PKU! @cclark2019 @danslowphelife
If you would like to grab your own copy, click here: a.co/d/0aPnD9g5
#PKU #PKUAwareness #Phenylketonuria #RareDisease #RareDiseaseAwareness #PatientWorthy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
